Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1834-1836, April 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xin, H.
Right arrow Articles by Böni, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xin, H.
Right arrow Articles by Böni, R.
[Cancer Research 59, 1834-1836, April 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

The Sebaceous Nevus

A Nevus with Deletions of the PTCH Gene

Hong Xin, David Matt, Jian-Zhong Qin, Günter Burg and Roland Böni1

Department of Dermatology, University Hospital, 8091 Zürich, Switzerland

Sebaceous nevi (SN) are congenital malformations of the skin with the potential to develop into basal cell carcinoma (BCC). To date, the molecular basis for their carcinogenic potential remains unknown. The genetic defect in BCC is known and involves the human homologue of Drosophilapatched (PTCH) on chromosome 9q22.3. The objective of this study was to test whether allelic deletion of the PTCH gene could already be detected in SN. Twenty-one paraffin-embedded SN were investigated in this study. Basaloid cells in conjunction with mature sebaceous glands as well as epidermal layer apart from SN were microdissected and subjected to single-step DNA extraction. We performed the analysis with polymorphic markers at 9q22.3 (D9S15, D9S252, D9S287, and D9S303). Of the 20 informative SN, 8 (40%) exhibited loss of heterozygosity at least at one locus. Here, we provide the first evidence of the involvement of the tumor suppressor gene PTCH in SN. Whether PTCH deletion in SN is associated with progression to BCC and/or other appendageal tumors should be addressed in future studies.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
K O Alsaad, N A Obaidat, and D Ghazarian
Skin adnexal neoplasms--part 1: An approach to tumours of the pilosebaceous unit
J. Clin. Pathol., February 1, 2007; 60(2): 129 - 144.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. S. Paller
Genetic Disorders of Skin: A Decade of Progress
Arch Dermatol, January 1, 2003; 139(1): 74 - 77.
[Full Text] [PDF]


Home page
Arch DermatolHome page
A. S. Paller
Expanding Our Concepts of Mosaic Disorders of Skin
Arch Dermatol, September 1, 2001; 137(9): 1236 - 1238.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.